Inform your business decisions - authoritative market research - reliable forecasts.

Learn more about our industry study - purchase by the page or the full report:

Biologics to 2015 - Demand and Sales Forecasts, Market Share, Market Size, Market Leaders

Biologics to 2015 - Industry Market Research, Market Share, Market Size, Sales, Demand Forecast, Market Leaders, Company Profiles, Industry Trends

US demand for biologics is expected to grow 6.5 percent annually through 2015, driven by dramatic shifts in production technology and more targeted diseases such as cancer, diabetes and other serious medical conditions. Monoclonal antibodies will remain the largest category and be one of the fastest growing segments, outpaced only by hormones.

This study analyzes the $74.3 billion US biologics industry. It presents historical demand data for the years 2000, 2005 and 2010, and forecasts for 2015 and 2020 by product (e.g., monoclonal antibodies, vaccines and toxoids, hormones, growth factors, immunomodulators, blood and blood products, enzymes, coagulation factors) and application (e.g., human health care, animal health, research).

The study also considers market environment factors, details industry structure, evaluates company market share and profiles 44 industry competitors, including Roche, Amgen and Sanofi-Aventis.

Purchase Options/View Brochure   


Table of Contents

INTRODUCTION

EXECUTIVE SUMMARY

MARKET ENVIRONMENT

General

Demographic Patterns

Macroeconomic Outlook

Healthcare Trends

National Health Expenditures

Pharmaceutical Supply & Demand

Pharmaceutical Shipments by Therapeutic Class

Patient Activity

Medical Conditions

Acute Conditions

Chronic Conditions

Animal Health Industry Outlook

Technological Overview of Biologics

Recombinant DNA Biologics

Biosimilars

Regulation

Regulation of Human Biologic Therapies

Regulation of Biosimilar Products

Regulation of Biologics Research & Testing Products

Regulation of Animal Biologics

PRODUCTS

General

Demand by Type

Monoclonal Antibodies

Cancer Treatment

Rheumatoid Arthritis

Macular Degeneration

Psoriasis

Infectious Disease

Other Applications

Vaccines & Toxoids

Vaccines for Human Health

Routine Immunizations

Influenza

Therapeutic Vaccines

Other Vaccines

Animal Vaccines

Hormones

Insulin

Human Growth Hormone

Teriparatide

Follicle-Stimulating Hormone

Estrogen

Calcitonin

Thyrotropin

Corticotropin

Other Hormones

Growth Factors

Erythropoietins

Colony-Stimulating Factors

Bone Morphogenetic Proteins

Other Growth Factors

Immunomodulators

Immunosuppressing Agents

Interferons

Other Immunomodulators

Blood & Blood Products

Plasma & Plasma Fractions

Whole Blood

Cellular Components

Enzymes

Enzyme Replacement Therapies

Neuromodulators

Digestive Enzymes

Thrombolytics

Diagnostics

Other Enzymes

Coagulation Factors

Antihemophilics

Other Coagulation Factors

Other Biologics

APPLICATIONS

General

Human Healthcare

Cancer

Autoimmune Diseases

Infectious Diseases

Blood Disorders

Diabetes

Other Conditions

Biologics for Other Uses

Animal Health

Research & All Other Applications

INDUSTRY STRUCTURE

General

Market Share

Competitive Strategies

Mergers & Acquisitions

Licensing & Related Agreements

Research & Development

Manufacturing

Marketing & Distribution

Company Profiles

Abbott Laboratories

Alere Incorporated

Alexion Pharmaceuticals Incorporated

Allergan Incorporated

Alnara Pharmaceuticals, see Eli Lilly

American Red Cross

Amgen Incorporated

Aptalis Pharma Incorporated

AstraZeneca plc

Axcan Intermediate Holdings, see Aptalis Pharma

Baxter International Incorporated

Bayer AG

BBI Enzymes, see Alere

Biogen Idec Incorporated

BioMarin Pharmaceutical Incorporated

BioVex Group, see Amgen

Blood Systems Incorporated

Bristol-Myers Squibb Company

Crucell, see Johnson & Johnson

CSL Limited

EKR Therapeutics Incorporated

Eli Lilly & Company

EMD Serono, see Merck KGaA

Emergent BioSolutions Incorporated

Enzon Pharmaceuticals, see sigma-tau Group

Eurand, see Aptalis Pharma

Facet Biotech, see Abbott Laboratories

Genentech, see Roche Holding

Genzyme, see Sanofi-Aventis

GlaxoSmithKline plc

GSK Biologicals, see GlaxoSmithKline

Halozyme Therapeutics Incorporated

Intercell AG

Inverness Medical Innovations, see Alere

Ipsen

Johnson & Johnson

Lonza Group Limited

Lundbeck (H.) A/S

Massachusetts Biologic Laboratories

Medarex, see Bristol-Myers Squibb

MedImmune, see AstraZeneca

Medtronic Incorporated

Mentor Worldwide, see Johnson & Johnson

Merck & Company Incorporated

Merck KGaA

Merial, see Sanofi-Aventis

New York Blood Center

Novartis AG

Novo Nordisk A/S

Organon Teknika, see Merck & Company

Ortho-McNeil-Janssen Pharmaceuticals, see Johnson & Johnson

Ovation Pharmaceuticals, see H. Lundbeck A/S

Percivia, see Johnson & Johnson

Pfizer Incorporated

Questcor Pharmaceuticals Incorporated

ratiopharm, see Teva Pharmaceutical Industries

Roche Holding Limited

Sandoz International, see Novartis

Sanofi-Aventis

Shire plc

sigma-tau Group

Solstice Neurosciences, see US WorldMeds

Solvay SA

Stryker Corporation

Teva Pharmaceutical Industries Limited

Theravance, see GlaxoSmithKline

TL Biopharmaceutical, see Lonza Group & Teva Pharmaceutical Industries

Trubion Pharmaceuticals, see Emergent BioSolutions

US WorldMeds LLC

Ventana Medical Systems, see Roche Holding

ViaCyte Incorporated

Vivante GMP Solutions, see Lonza Group

WiCell Research Institute

Wisconsin International Stem Cell Bank, see WiCell Research Institute

Wyeth, see Pfizer

ZyStor Therapeutics, see BioMarin Pharmaceutical

Other Companies Mentioned in Study


List of Tables

EXECUTIVE SUMMARY

Summary Table

MARKET ENVIRONMENT

Population & Households

Macroeconomic Indicators

National Health Expenditures by Type & Source of Payment

Pharmaceutical Supply & Demand

Pharmaceutical Shipments by Therapeutic Class

Patient Activity

Medical Conditions

Animal Population & Veterinary Health Expenditures

PRODUCTS

Biologics Demand by Type

Monoclonal Antibodies Demand

Vaccines Demand

Hormones Demand

Growth Factors Demand

Immunomodulators Demand

Blood & Blood Products Demand

Enzymes Demand

Coagulation Factors Demand

Other Biologics Demand

APPLICATIONS

Biologics Demand by Application

Biologics Demand for Human Healthcare by Condition & Use

Cancer Biologics Demand

Autoimmune Biologics Demand

Infectious Diseases Biologics Demand

Blood Disorders Biologics Demand

Diabetes Biologics Demand

Other Human Health Biologics Deman by Condition & Product

Biologics Demand for Other Applications

INDUSTRY STRUCTURE

US Biologics Sales by Company, 2010

Selected Acquisitions & Divestitures

Selected Cooperative Agreements


List of Charts

PRODUCTS

Biologics Demand by Product Type, 2010

APPLICATIONS

Human Healthcare Biologics Demand by Conditio & Use, 2010

INDUSTRY STRUCTURE

US Biologics Market Share, 2010


© by The Freedonia Group, Inc.


You may view the complete table of contents without charge and select individual records for purchase ($35.00 text | $60 table each) or purchase the complete study.

Home  About Freedonia  Contact Freedonia  Search Studies  Browse Catalog

The Freedonia Group - The First Choice In Industry Research©

www.freedoniagroup.com
All Rights Reserved 

© The Freedonia Group
767 Beta Drive Cleveland Ohio 44143